Fluorinated drugs now make up about 25% of all pharmaceuticals. However, versatile carriers are currently lacking for the delivery of fluorinated drugs. Here, we developed a fluorodendrimer as a versatile and multifunctional carrier for fluorinated drugs. The fluorodendrimer enables the co-delivery of fluorinated anticancer drugs and therapeutic genes for synergistic cancer therapy.
H. Wang, J. Hu, X. Cai, J. Xiao and Y. Cheng, Polym. Chem., 2016, 7, 2319 DOI: 10.1039/C6PY00153J
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Please wait while we load your content...
